Novartis AG vs Occidental Petroleum Corporation — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Occidental Petroleum Corporation trades at $56.45 (market cap $54.89B). The key difference: Novartis AG is far larger — about 5.3× Occidental Petroleum Corporation's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | OXY | |
|---|---|---|
Market Cap | $290.25B | $54.89B |
Sector | Health | Energy |
52-Week High | $168.62 | $66.24 |
52-Week Low | $113.50 | $38.92 |
Enterprise Value | $330.27B | $75.98B |
Dividend Yield | 3.17% | 1.88% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →